Study on Europium Doped Hydroxyapatite Nanoparticles by Fourier Transform Infrared Spectroscopy and Their Antimicrobial Properties by Iconaru, Simona Liliana et al.
Study on Europium Doped Hydroxyapatite
Nanoparticles by Fourier Transform Infrared
Spectroscopy and Their Antimicrobial Properties
Simona Liliana Iconaru, Mikael Motelica-Heino, Daniel Predoi
To cite this version:
Simona Liliana Iconaru, Mikael Motelica-Heino, Daniel Predoi. Study on Europium
Doped Hydroxyapatite Nanoparticles by Fourier Transform Infrared Spectroscopy and
Their Antimicrobial Properties. Journal of Spectroscopy, 2013, Article ID 284285, 10 p.
<10.1155/2013/284285>. <insu-00852201>
HAL Id: insu-00852201
https://hal-insu.archives-ouvertes.fr/insu-00852201
Submitted on 20 Aug 2013
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.
Study on europium doped hydroxyapatite nanoparticles by Fourier transform infrared 
spectroscopy and their antimicrobial properties 
 
Simona Liliana Iconaru1,2, Mikael Motelica-Heino2, Daniela Predoi1* 
1Department of Multifunctional Materials and Structures Laboratory, National Institute of 
Materials Physics, 105 BisAtomistilor, P.O. Box MG 07, 077125 Magurele, 
Romania,1*dpredoi@gmail.com 
2ISTO, Université d’Orléans, Orléans cedex 02, 45067, France 
 
 
Abstract 
 
In this work, Fourier Transform Infrared spectroscopy (FT-IR) analysis were 
conducted on europium doped hydroxyapatite, Ca10-xEux(PO4)6(OH)2 nanocrystalline 
powders (Eu:HAp) with 0 ≤ xEu ≤ 0.2. Antimicrobial studies were also performed for the first 
time on Eu:Hap. The antimicrobial properties of Eu:HAp nanoparticles  with  0 ≤ xEu ≤ 0.2 on 
Gram-negative (E coli ATCC 25922, Pseudomonas aeruginosa 1397) and Gram-positive 
(Staphylococcus aureus 0364, Enterococcus faecalis ATCC 29212) bacteria systems and a 
species of fungus (Candida albicans ATCC 10231) were reported. Our study demonstrates 
that the antimicrobial activity of Eu:HAp nanoparticles is dependent on the europium 
concentration. 
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1. Introduction 
 
Hydroxyapatite ( Ca10(PO4)6(OH)2 ) is the main inorganic component of human bones 
and teeth, showing a very good biocompatibility, bioactivity and osteoconductivity due to its 
nontoxic, and noninﬂammatory properties [1-9]. Therefore, it has been widely used in many 
fields, like bio-medical applications, as a bioactive coating material for metallic implants, 
clinical bone augmentation, dental implantology, tumors treatment and cell activation, or it 
could be also used as a carrier in drug delivery systems [10]. Moreover, trivalent rare-earth-
ion-doped hydroxyapatite can also be used as biological ﬂuorescent probes due to their 
excelent luminescent properties.  
In the last years, luminescence imagining, especially in the region of near-infrared 
spectrum showed a great interest for biomedical applications, focusing on the development 
and characterization of rare-earth based inorganic luminescent nanoparticules [11-14]. The 
most important applications could be found on pharmaceutical industry or biological and 
medical diagnostics [15-17].  
When doped with rare-earth ions, hydroxyapatite is being considered a fluorescent 
probe, the luminescence intensity depending on the concentration of rare-earth’s doping ions, 
the degree of crystallinity and the crystal structure of the host material [18-20]. Over the past 
decade, several methods for obtaining luminescent inorganic nanoparticles have been 
developed, including coprecipitation and sol-gel synthesis which allow to adjust particles 
morphology, size, structure and composition in order to adapt their physical and chemical 
properties [14, 21-23]. 
Fluorescent labeling is an indispensable technique which is widely used for 
performing nondestructive observations both in vivo and in vitro by replacing the calcium 
ions in hydroxyapatite crystal lattice using rare earth luminescent ions [24-26]. The 
hexagonal hydroxyapatite allows the substitutions of many rare earth ions without any 
changes in the crystal structure [27-30]. Nowadays, the rare earths ions doped hydroxyapatite 
nanoparticles are being studied very intently as cell labeling materials, as a result of their 
strong luminescence under visible light spectrum. [31-36] 
Compared to other rare earth elements, trivalent Europium Eu3+ ions have a simple 
electronic energy level scheme and hypersensitive transitions. The Eu3+ doped calcium 
apatites represent a good biological probe candidate due to their low toxicity and stable 
luminescence over time and it has been proven that a small amount of europium in the 
bioactivity behaviour has no harmful effects [37-41]. The ionic radius similarity between 
Ca2+ and Eu3+ in the apatite lattice makes them a good host for Eu3+ doping [4]. 
Recently, great attention has been paid to europium doped hydroxyapatite (Eu:HAp) 
potential use as biological probe [30]. Previously, the europium doped hydroxyapatite was 
studied applying PL [32-33]. On the other hand, IR spectroscopy is a powerful method in 
ionic investigation and has been used extensively in phosphate minerals research [42–44]. 
Concerning the phase composition of the as-prepared Eu:HAp various studies have 
been reported [31-33, 45]. In our recent studies no other additional phases were observed [45] 
for the synthesized Eu:HAp samples and the diffraction patterns were identical to that 
obtained for stoichiometric apatite. In this paper, the obtained Eu:Hap samples were 
systematically characterized by Fourier transform infrared (FTIR) spectroscopy. The aim of 
this work is to contribute to the study of the influence of europium in the structure of 
hydroxyapatite. On the other hand, cell viability from various doses of the Eu:HAp samples 
at two different time points were compared with corresponding culture media values.After 24 
h and 48h exposure to all types of Eu:HAp at 10 μg /ml concentration, the morphology of the 
cells was preserved. Moreover, we report in this work for the first time the bacterial studies 
on Eu:HAp. Furthermore, in this article, original stidies on antimicrobial activities of Eu:HAp 
against Gram-positive (Staphylococcus aureus 0364, Enterococcus faecalis ATCC 29212), 
Gram-negative (E coli ATCC 25922, Pseudomonas aeruginosa 1397) and fungal strains 
(Candida albicans ATCC 10231) are presented. 
 
2. Materials and methods  
 
2.1. Samples 
 
All the reagents for synthesis, including ammonium dihydrogen phosphate 
[(NH4)2HPO4], calcium nitrate [Ca (NO3)24H2O], and europium nitrate [Eu(NO3)36H2O] 
(Alpha Aesare) were used as purchased, without purification. Europium doped 
hydroxyapatite (Eu:Hap, Ca10-xEux(PO4)6(OH)2) nanoparticles were performed by setting xEu 
= 0.01, xEu = 0.02,xEu = 0.05, xEu = 0.1, xEu = 0.2 and [Ca+Eu]/P as 1.67 in accord with [45].  
 
2.2. Fouriertransforms infrared (FTIR) spectroscopy.  
 
The functional groups present in the prepared nanoparticles and thin films were 
identified by FTIR using a Perkin Elmer, Spectrum BX spectrometer. In order to obtain the 
nanoparticles spectra, 1% of the nanopowder was mixed and ground with 99% KBr. Tablets 
of 10 mm diameter were prepared by pressing the powder mixture with a pressure of not 
more than 10 psi. The spectrum was recorded in the range of 400 to 4000 cm-1 with 4 cm-1 
resolution. The first FTIR spectra were obtained after 256 scans at room temperature(25 ± 
0.50C). The second derivative IR spectra were acquired after 5-point smoothing of the 
original IR spectra.For selected spectral ranges, the peak fitting analyses were performed 
using procedures of J. Kolmas et al. [46]: (i) baseline correction, (ii) second derivative 
calculation and self deconvolution assessment in order to determine the number and positions 
of the bands and (iii) curve fittings with fixed peak positions using Lorentzienne lines. In the 
previous studies Matsuhiro et al. [47] and Gómez-Ordóñezet al. [48] showed thatsecond-
derivatives of FTIR spectra are generally used as an aid for wave number determination of 
weak absorption bands onto improve resolution of overlapped bands in the originalspectra.To 
that end, in our studies derivation including Savitzky-Golay algorithm with nine smoothing 
points was performed. 
 
2.3. Antimicrobial studies.  
 
The microbial strains identification was confirmed by aid of VITEK II automatic 
system. VITEK cards for identification and susceptibility testing were inoculated and 
incubated according to the manufacturer's recommendations. Microbial suspensions of 
1.5x108 CFU/mL corresponding to 0.5 McFarland density obtained from 15-18 h bacterial 
cultures developed on solid media were used in our experiments. The tested substances were 
solubilised in DMSO and the starting stock solution was of 5000 μg/mL concentration. The 
qualitative screening was performed by an adapted disk diffusion method [49-53]. 
 
3. Results and discussions 
 
3.1. IR Absorbance Spectra 
 
The FTIR spectra of Eu:HAp were recorded in the typical, absorption mode from KBr 
pellets.IR absorbance spectra of EuHAp samples with various europium concentrations (0 ≤ 
xEu  ≤ 0.2) are shown in the 4000 cm-1 to 400 cm-1 range in Figure 1. Inourpreviousstudies 
[45] we haveshown that for all the samples the presence of strong [OH]- vibration peak (632 
cm−1) could be noticed. The broad bands in the regions 1600–1700 cm−1 and 3200–3600 
cm−1 correspond to H–O– H bands of lattice water. Fowler B.O. in his infrared studies on 
apatites [54] showed that the band at 3570 cm−1 is characterized by [OH]- stretching mode 
and the band at 632 cm−1 characterized by [OH]- arises from stretching librational mode.  The 
bands at around 1090 cm−1 and about1040 cm−1 can be attributed to the 3 [PO4]3- while the 
band at 962 arises from 1 [PO4]3-. The 602 cm−1 and 564 cm−1 bands appear from 4 [PO4]3-. 
Markovik et al. [55], presented that the sharpness of bands, especially sharpness of the 632 
cm−1, 602 cm−1 and 564 cm−1 bands indicate a well-crystallized HAp. The band at 475 cm−1 
can be attributed to the 2 [PO4]3- [56]. In the FT-IR spectrum of Eu:HAp with xEu  0.1 
(Figure 1) the bands corresponding to the 3 vibration of C–O were observed at 1410 cm−1, 
characteristic of the carbonate group [57-58]. 
 
 
Figure 1: FT-IR spectra of europium doped hydroxyapatite (Eu:HAp)  
with xEu = 0, xEu = 0.02, xEu = 0.2. 
 
The intensity of the band located at 1410 cm−1 in the spectrum of Eu:HAp samples 
with xEu  0.1 is attributed to components of the 3  mode of a trace amount of [CO3]2-. The 
2 vibrations between 850 and 890 cm−1, characteristic of the carbonate group were not 
detected because 2 [CO3]2- band at 872 cm−1 is hidden by [HPO4]2- band at 875 cm-1. 
Similar comportment was observed by Markovik et al. [55] in his studies on preparation and 
comprehensive characterization of calcium hydroxyapatite. Markovik et al. and Holcomb 
D.W. et al. [59] showed that the [CO3]
2- band at 1410 cm−1 derives from [CO3]
2- (designated 
by “B-type” carbonate that replace PO43- ions in the hydroxyapatite lattice). The band at 1510 
cm−1was also detected in the FT-IR spectrum of Eu:HAp with xEu  0.1. The band at 1510 
cm−1 derives from [CO3]
2- (designated by “A-type” carbonate) that replacesOH- ions in the 
hydroxyapatite lattice [55, 60]. In all the spectra of Eu:HAp samples, the band at 875 cm-1 
was detected. This band is supposed to arise due to [HPO4]
2- ions from several reasons [55]. 
In Figure 1 we observed that the contribution of the area that corresponds to the 
phosphate bands decreases when the europium concentration in the samples increases. The 
bands at 475 and 962 cm−1 progressively disappear with the increase of europium 
concentration. When the xEu = 0.2 the bands  at 475 and 962 cm
−1 are almost absent. We can 
also observe in the Eu:HAp spectra a broadening of peak vibration with the decrease of the 
europium concentration. This behaviour was observed by Owada et al. [61] in sintered Y-
doped hydroxyapatite. 
 
3.2. IR Second Derivative Spectra 
 
In order to complete structural information on the analyzed Eu:HAp samples with 0 ≤ 
xEu  ≤ 0.2 we agreed to perform derivative analysis and peak fitting of selected 4, 3, 2 and 
1phosphate bands. The second derivative of the spectrum of Eu:HAp samples (xEu = 0, xEu = 
0.02, xEu = 0.2) in the 4, 3 and 1 [PO4]3- bands are shown in Figure 2.Only the results 
obtained for pure HAp (xEu = 0) and Eu:HAp (xEu = 0.02, xEu = 0.2) samples are shown, 
which clearly assigned the strong changes that occur in the FT-IR spectra of HAp in the 
presence of Eu. 1 [PO4]3- band was observed at around 962 cm-1 in the second derivative 
spectra. On the other hand, in the second derivative spectra was identified a 2 [PO4]3- band at 
475 cm-1. In concordance with precedent studies, the bands assigned in the second derivative 
spectra of Eu:HAp (0 ≤ xEu ≤ 0.2) can beattributed to molecular vibrations of the phosphate 
[PO4]
3- in a apatitic stoichiometric environment of hydroxyapatite [62].  
To evaluate the subtle spectral changes occurring as a consequence of the europium  
doped hydroxyapatite, the spectra in the spectral regions of 450–700 cm-1(2and 4 [PO4]3- 
domain) and 900–1200 cm-1(1 and 3 [PO4]3- domains) were analyzed by means of second 
derivative (Figure 2) and curve fitting analysis (Figure 3). 
In Figure 2 we also observethe second derivative band at 633 cm-1 that derives from 
the OH- librational mode. IR wavenumber position (cm-1) of the 4, 3, 2and 1 [PO4]3- bands 
of Eu:HAp spectrum from second derivative is presented in Table 1. Ten bands were detected 
for phosphate bands of hexagonal Eu:HAp samples. 
 
Table 1. IR wavenumber position (cm-1) of 4, 3, 2 and 1 [PO4]3- bands of Eu:HAp 
spectrum from second derivative. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 shows the FT-IR spectrum of hydroxyapatite (xEu = 0), the phosphate 4, 3, 
2 and 1 regionswith experimental and calculated contours overlaid along with the individual 
subbands (blue) as determined by a curve fitting analysis. Five components were needed for a 
satisfactory fit in the spectral region of 450–700 cm-1 (2 and 4 [PO4]3- domain) and eight in 
the spectral region of 900–1200 cm-1(1 and 3 [PO4]3- domains). FT-IR spectrum of Eu:Hap 
with xEu = 0.02 is also presented and five components were needed for a satisfactory fit in the 
spectral region of 450–700 cm-1(2 and 4 [PO4]3- domain) and six in the spectral region of 
900 –1200 cm-1(1 and 3 [PO4]3- domains). For Eu:Hap samples withxEu =0.2 four 
components were needed for a satisfactory fit in the spectral region of 450–700 cm-1 (2 and 
4 [PO4]3- domain) and five important components in the spectral region of 900–1200 cm-1 (1 
and 3 [PO4]3- domains). 
Assignments Position (cm-1) References 
1 [PO4]3-   962 62 
2 [PO4]3-   475 62 
3 [PO4]3- 1033;   1045;   1073;   
1090 
62 
4 [PO4]3-   569;     575;     588;     
602 
62 
Present in newly precipitated 
apatite. 
1111 62-63 
[HPO4]2-- containing apatites 1144 63 
[OH]- group ( librational mode) 633 63-64 
  
 
 
 
 
Figure 2: Second derivative of Eu:HAp (xEu = 0, xEu = 0.02, xEu = 0.2) spectrum 
of the 4, 3, 2 and 1domains. 
 
  
 
Figure 3: FT-IR deconvoluted spectra of the 4, 3, 2 and 1 domain  
for Eu:HAp (xEu = 0, xEu = 0.02, xEu = 0.2). 
 
The individual component for phosphate 2 region (featured near 475 cm-1) decreases 
for the samples with xEu = 0.02 and disappears when xEu increases to 0.2. The high frequency 
shoulder is more clearly defined for pure HAp than in the case of the Eu:HAp with xEu = 0.02 
and xEu = 0.2 in the 1 and 3 phosphate regions. The band requires at least eight components 
for an adequate fit to the spectrum, compared with only six in the case of Eu:HAp with xEu = 
0.02 or only five in the Eu:HAp with xEu = 0.2. In this series of materials it was not realistic 
to attempt to identify particular components characteristic the particle size.  However, a 
correlation was found between the percentage area of the 1, band (near 960 cm-1) and the 
crystal size. The individual component for the phosphate 1 region (band near 960 cm-1) 
disappears when xEu increases to 0.2. On the other hand, the individual component for 
phosphate 3 region (band near 1040 cm-1) decreases for the samples with xEu = 0.02. 
However, in the Figure 2 and 3, we observe the disappearance of the band at 1144 cm-1, 
which is associated with [HPO4]
2- ions [65].We note that the main molecular species that 
gave rise to the Eu:Hap (xEu = 0, xEu = 0.02, xEu = 0.2) absorbance in the 900-1200 cm
-1 
region was assigned to the phosphate ion, [PO4]
3-. 
 
3.3. Antimicrobial studies 
 
A study on  enhancement of osteoblast proliferation on europium doped 
hydroxyapatite  has rarely  been reported. Anselme K. [66] in his study concerning osteoblast 
adhesion on biomaterials and Garcia AJ, et al. [67] in the study of bio-adhesive surfaces to 
promote osteoblast differentiation and bone formation showed that often synthetic materials 
do not support osteoblast adhesion and this may result in poor cell differentiation and limited 
bone formation. Keselowsky BG et al. [68] in the  study on surface chemistry and Mc Farland 
CD et al.[69] in his study on protein adsorption and cell attachment to patterned surfaces 
demonstrated that the effect of surface properties on cellular response depends on differences 
in species, concentration, and biological activity of adsorbed proteins, which may be obtained 
from different sources, i.e., biological fluids and cell-mediated synthesis and deposition.  
The antimicrobial activity of Eu:HAp (0 ≤ xEu ≤ 0.2) nanoparticles was tested using 
the most common bacterial pathogens and fungus: E coli ATCC 25922 (Gram-negative), 
Pseudomonas aeruginosa 1397 (Gram-negative), Staphylococcus aureus 0364 (Gram-
positive), Enterococcus faecalis ATCC 29212 (Gram-positive) and Candida albicans ATCC 
10231 (fungus). 
The antimicrobial studies on Eu:HAp (0 ≤ xEu ≤ 0.02) nanoparticles indicated that 
antimicrobial activity is present.The results of antimicrobial activity of Eu:HAp (0.05 ≤ xEu ≤ 
0.2) nanoparticles are shown in Figures 4-6. For the as-prepared Eu:HAp samples an 
antibacterial activity was not observed on E coli ATCC 25922 (Figures 4-6). The Eu:HAp 
nanoparticles with xEu = 0.05 showed a good antibacterial activity on Enterococcus faecalis 
ATCC 29212) (Figure 6) for all the concentrations studied (from 0.031 mg/ml to 1 mg/ml). 
For the samples of Eu:HAp with  xEu = 0.1 and xEu = 0.2 (Figures 5-6) we have observed that 
the inhibition of Enterococcus faecalis ATCC 29212) was more evident. In the samples with 
xEu = 0.1, the inhibition was observed for concentrations higher than 0.062 mg/ml. For the as-
prepared Eu:Hap samples with xEu = 0.2 the inhibition was observed for all concentrations. 
For Candida albicans ATCC 10231 a good inhibition was observed for samples with xEu = 
0.2 (Figure 6). 
 
 
Figure 4:Antimicrobial activity of as-prepared Eu:HAp samples (xEu = 0.05) on E coli ATCC 
25922, Pseudomonas aeruginosa 1397, Staphylococcus aureus 0364, Enterococcus 
faecalisATCC 29212 and Candida albicans ATCC 10231. 
 
 
 
 
 
 
 
 
 
Figure 5: Antimicrobial activity of as-prepared Eu:HAp samples (xEu = 0.1) on E coli ATCC 
25922, Pseudomonas aeruginosa 1397, Staphylococcus aureus 0364, Enterococcus faecalis 
ATCC 29212 and Candida albicans ATCC 10231. 
 
 
 
Figure 6: Antimicrobial activity of as-prepared Eu:HAp samples (xEu = 0.2) on E coli ATCC 
25922, Pseudomonas aeruginosa 1397, Staphylococcus aureus 0364, Enterococcus faecalis 
ATCC 29212 and Candida albicans ATCC 10231. 
 
For samples with xEu = 0.05   and xEu = 0.1 the inhibition was observed at high 
concentrations (Figures 4-6). Additionally, a very good inhibition of Pseudomonas 
aeruginosa 1397 has been noticed when the concentration of Eu:Hap (0.05 ≤ xEu ≤ 0.2) 
increased from 0.125 mg/ml to 1 mg/ml. Raimondi et al. [70] and Morones et al.[71], 
studying the inhibition of bacterial growth by differentially shaped nanoparticles, showed that 
the antimicrobial efficacy of the nanoparticles depends on the shape of the nanoparticles.  
 
One of the aims of this study was to obtain an Eu:Hap stoichiometric apatite and to 
contribute to the study of the influence of europium in the structure of hydroxyapatite. We 
note that it is possible to determine the type of apatite, nonstoichiometric or stoichiometric, 
using Fourier deconvolution techniques. This study allowed highlighting the stoichiometry of 
Eu:HAp biomaterials, based on changes in the phosphate 1 and 3 absorbances in the 900-
1200 cm-1 spectral region. The Sauer GR et al. [72] in their studies claimed that the presence 
of the [PO4]
3- doublet at 602 and 567 cm-1 in all the composites suggest that the precursor 
phase of the HAp was octacalcium phosphate, OCP, (Ca8H2[PO4]6). On the other hand, they 
showed that the OCP precursor ensures a more crystalline and ordered HAp phase. Granja PL 
et al. [73] in their previous studies have affirmed that if the precursor had been amorphous 
calcium phosphate (ACP) (Ca2[PO4]3), these [PO4]
3- bands should be a broad singlet instead 
of a doublet. Moreover, Hutchens SA et al. in 2006 [74] evidenced that ACP precipitation 
requires the rapid interaction between Ca2+ and [PO4]
3-at high supersaturation instead of 
precursor complexation with other species. A previous study of apatite minerals realized by 
Rey et al. in 1991 [75], using Fourier deconvolution analysis, has attributed a 1020 cm-1 band 
to nonstoichiometric apatite containing [HPO4]
2- and [CO3]
2-, and the band at  1125cm-1in 
FT-IR deconvoluted spectra to stoichiometric apatite. Due to the presence of the band at 
around 1127 cm-1 in all the prepared samples, our present studies have shown that the 
Eu:HAp is a stoichiometric apatite. 
Moreover, our present study demonstrates that the antibacterial activity of Eu:HAp 
nanoparticles is dependent on the europium concentration. Furthermore, the inhibitory effect 
was found to be dependent to the increase of concentration from 0.031 mg/ml to 1 mg/ml.  
 
Conclusions 
 
In the present work, we contributed to the study of the influence of europium in 
structure of hydroxyapatite. Using Fourier deconvolution techniques we showed that it is 
possible to determine the type of Eu:HAp apatite, nonstoichiometric or stoichiometric. The 
spectra of Eu:Hap samples  in the spectral regions of 450–700 cm-1 and 900–1200 cm-1 were 
analyzed by means of second derivative and using Fourier deconvolution analysis. This study 
allowed highlighting the stoichiometry of Eu:HAp  biomaterials, based on changes in the 
phosphate 1 and 3 absorbances in the 900-1200 cm-1 spectral region. 
The antimicrobial activity of Eu:HAp (0 ≤ xEu ≤ 0.2) nanoparticles was tested using 
the most common bacterial pathogens and fungus: E coli ATCC 25922 (Gram-negative), 
Pseudomonas aeruginosa (Gram-negative), Staphylococcus aureus 0364 (Gram-positive), 
Enterococcus faecalis ATCC 29212 (Gram-positive) and Candida albicans ATCC 
10231(fungus).  
In summary, this study on the antimicrobial activity of Eu:HAp (0 ≤ xEu ≤ 0.2) 
nanoparticlesdescribes a nanotechnology-based strategy luminescent Eu3+ doped 
hydroxyapatite represents a potential application for drug release and targeting based on their 
luminescent properties. These results and methods could be interesting for academic and 
industrial researchers in biomaterials, potential orthopedic medical materials and drug 
carriers.   
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